{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:28:28Z","timestamp":1778876908775,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/cgt.2017.3","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T11:21:16Z","timestamp":1486725676000},"page":"180-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial\u2013mesenchymal transition"],"prefix":"10.1038","volume":"24","author":[{"given":"H","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"key":"BFcgt20173_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cell.2008.03.026","volume":"133","author":"H Sun","year":"2008","unstructured":"Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 2008; 133: 415\u2013426.","journal-title":"Cell"},{"key":"BFcgt20173_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cell.2008.04.017","volume":"133","author":"EC Freundt","year":"2008","unstructured":"Freundt EC, Bidere N, Lenardo MJ . A different TIPE of immune homeostasis. Cell 2008; 133: 401\u2013402.","journal-title":"Cell"},{"key":"BFcgt20173_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.molimm.2011.08.006","volume":"49","author":"Y Lou","year":"2011","unstructured":"Lou Y, Liu S . The TIPE (TNFAIP8) family in inflammation, immunity, and cancer. Mol Immunol 2011; 49: 4\u20137.","journal-title":"Mol Immunol"},{"key":"BFcgt20173_CR4","doi-asserted-by":"publisher","first-page":"15413","DOI":"10.1073\/pnas.1204525109","volume":"109","author":"Z Wang","year":"2012","unstructured":"Wang Z, Fayngerts S, Wang P, Sun H, Johnson DS, Ruan Q et al. TIPE2 protein serves as a negative regulator of phagocytosis and oxidative burst during infection. Proc Natl Acad Sci USA 2012; 109: 15413\u201315418.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt20173_CR5","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.4049\/jimmunol.1103477","volume":"189","author":"H Sun","year":"2012","unstructured":"Sun H, Zhuang G, Chai L, Wang Z, Johnson D, Ma Y et al. TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway. J Immunol 2012; 189: 2768\u20132773.","journal-title":"J Immunol"},{"key":"BFcgt20173_CR6","doi-asserted-by":"publisher","first-page":"e96508","DOI":"10.1371\/journal.pone.0096508","volume":"9","author":"Y Lou","year":"2014","unstructured":"Lou Y, Zhang G, Geng M, Zhang W, Cui J, Liu S . TIPE2 negatively regulates inflammation by switching arginine metabolism from nitric oxide synthase to arginase. PLoS ONE 2014; 9: e96508.","journal-title":"PLoS ONE"},{"key":"BFcgt20173_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.molimm.2011.08.016","volume":"49","author":"YY Luan","year":"2011","unstructured":"Luan YY, Yao YM, Zhang L, Dong N, Zhang QH, Yu Y et al. Expression of tumor necrosis factor-alpha induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice. Mol Immunol 2011; 49: 219\u2013226.","journal-title":"Mol Immunol"},{"key":"BFcgt20173_CR8","doi-asserted-by":"crossref","first-page":"30178","DOI":"10.18632\/oncotarget.8398","volume":"7","author":"YY Luan","year":"2016","unstructured":"Luan YY, Yao RQ, Tong S, Dong N, Sheng ZY, Yao YM . Effect of tumor necrosis factor-alpha induced protein 8 like-2 on immune function of dendritic cells in mice following acute insults. Oncotarget 2016; 7: 30178\u201330192.","journal-title":"Oncotarget"},{"key":"BFcgt20173_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.clim.2009.08.014","volume":"133","author":"D Li","year":"2009","unstructured":"Li D, Song L, Fan Y, Li X, Li Y, Chen J et al. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol 2009; 133: 422\u2013427.","journal-title":"Clin Immunol"},{"key":"BFcgt20173_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000438633","volume":"38","author":"F Li","year":"2016","unstructured":"Li F, Zhu X, Yang Y, Huang L, Xu J . TIPE2 alleviates systemic lupus erythematosus through regulating macrophage polarization. Cell Physiol Biochem 2016; 38: 330\u2013339.","journal-title":"Cell Physiol Biochem"},{"key":"BFcgt20173_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/sji.12110","volume":"78","author":"Y Ma","year":"2013","unstructured":"Ma Y, Liu X, Wei Z, Wang X, Wang Z, Zhong W et al. The expression and significance of TIPE2 in peripheral blood mononuclear cells from asthmatic children. Scand J Immunol 2013; 78: 523\u2013528.","journal-title":"Scand J Immunol"},{"key":"BFcgt20173_CR12","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1159\/000438595","volume":"37","author":"J Ding","year":"2015","unstructured":"Ding J, Su J, Zhang L, Ma J . Crocetin activates Foxp3 through TIPE2 in asthma-associated treg cells. Cell Physiol Biochem 2015; 37: 2425\u20132433.","journal-title":"Cell Physiol Biochem"},{"key":"BFcgt20173_CR13","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.4049\/jimmunol.1300053","volume":"191","author":"Y Lou","year":"2013","unstructured":"Lou Y, Liu S, Zhang C, Zhang G, Li J, Ni M et al. Enhanced atherosclerosis in TIPE2-deficient mice is associated with increased macrophage responses to oxidized low-density lipoprotein. J Immunol 2013; 191: 4849\u20134857.","journal-title":"J Immunol"},{"key":"BFcgt20173_CR14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.4049\/jimmunol.1400415","volume":"193","author":"Y Lou","year":"2014","unstructured":"Lou Y, Sun H, Morrissey S, Porturas T, Liu S, Hua X et al. Critical roles of TIPE2 protein in murine experimental colitis. J Immunol 2014; 193: 1064\u20131070.","journal-title":"J Immunol"},{"key":"BFcgt20173_CR15","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.molimm.2011.03.002","volume":"48","author":"W Xi","year":"2011","unstructured":"Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y et al. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol Immunol 2011; 48: 1203\u20131208.","journal-title":"Mol Immunol"},{"key":"BFcgt20173_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.molimm.2014.11.019","volume":"64","author":"W Zhang","year":"2014","unstructured":"Zhang W, Zhang J, Zhao L, Shao J, Cui J, Guo C et al. TIPE2 protein negatively regulates HBV-specific CD8(+) T lymphocyte functions in humans. Mol Immunol 2014; 64: 204\u2013209.","journal-title":"Mol Immunol"},{"key":"BFcgt20173_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2012.01.006","volume":"45","author":"Y Gus-Brautbar","year":"2012","unstructured":"Gus-Brautbar Y, Johnson D, Zhang L, Sun H, Wang P, Zhang S et al. The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell 2012; 45: 610\u2013618.","journal-title":"Mol Cell"},{"key":"BFcgt20173_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrc3252","volume":"12","author":"GK Alderton","year":"2012","unstructured":"Alderton GK . Tumour immunology: suppressing tumorigenic inflammation. Nat Rev Cancer 2012; 12: 228.","journal-title":"Nat Rev Cancer"},{"key":"BFcgt20173_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1476-4598-12-149","volume":"12","author":"X Cao","year":"2013","unstructured":"Cao X, Zhang L, Shi Y, Sun Y, Dai S, Guo C et al. Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1. Mol Cancer 2013; 12: 149.","journal-title":"Mol Cancer"},{"key":"BFcgt20173_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bbrc.2014.12.080","volume":"457","author":"Y Li","year":"2015","unstructured":"Li Y, Li X, Liu G, Sun R, Wang L, Wang J et al. Downregulated TIPE2 is associated with poor prognosis and promotes cell proliferation in non-small cell lung cancer. Biochem Biophys Res Commun 2015; 457: 43\u201349.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcgt20173_CR21","doi-asserted-by":"publisher","first-page":"e0126176","DOI":"10.1371\/journal.pone.0126176","volume":"10","author":"QQ Liu","year":"2015","unstructured":"Liu QQ, Zhang FF, Wang F, Qiu JH, Luo CH, Zhu GY et al. TIPE2 Inhibits Lung Cancer Growth Attributing to Promotion of Apoptosis by Regulating Some Apoptotic Molecules Expression. PLoS ONE 2015; 10: e0126176.","journal-title":"PLoS ONE"},{"key":"BFcgt20173_CR22","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1159\/000438596","volume":"37","author":"B Deng","year":"2015","unstructured":"Deng B, Feng Y . TIPE2 mediates the suppressive effects of Shikonin on MMP13 in osteosarcoma cells. Cell Physiol Biochem 2015; 37: 2434\u20132443.","journal-title":"Cell Physiol Biochem"},{"key":"BFcgt20173_CR23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/jcb.25068","volume":"116","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Zhao M, Dong T, Zhou C, Peng Y, Zhou X et al. Tumor necrosis factor-alpha-induced protein-8 like-2 (TIPE2) upregulates p27 to decrease gastic cancer cell proliferation. J Cell Biochem 2015; 116: 1121\u20131129.","journal-title":"J Cell Biochem"},{"key":"BFcgt20173_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/cgt.2016.6","volume":"23","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Tao M, Wu J, Meng Y, Xu C, Tian Y et al. Adenovirus-directed expression of TIPE2 suppresses gastric cancer growth via induction of apoptosis and inhibition of AKT and ERK1\/2 signaling. Cancer Gene Ther 2016; 23: 98\u2013106.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt20173_CR25","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.3892\/or.2016.4562","volume":"35","author":"Y Peng","year":"2016","unstructured":"Peng Y, Zhao Q, Zhang H, Han B, Liu S, Han M . TIPE2, a negative regulator of TLR signaling, regulates p27 through IRF4-induced signaling. Oncol Rep 2016; 35: 2480\u20132486.","journal-title":"Oncol Rep"},{"key":"BFcgt20173_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3892\/ijo.2014.2725","volume":"46","author":"YH Zhang","year":"2015","unstructured":"Zhang YH, Yan HQ, Wang F, Wang YY, Jiang YN, Wang YN et al. TIPE2 inhibits TNF-alpha-induced hepatocellular carcinoma cell metastasis via Erk1\/2 downregulation and NF-kappaB activation. Int J Oncol 2015; 46: 254\u2013264.","journal-title":"Int J Oncol"},{"key":"BFcgt20173_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3233\/CBM-140402","volume":"14","author":"XM Li","year":"2014","unstructured":"Li XM, Su JR, Yan SP, Cheng ZL, Yang TT, Zhu Q . A novel inflammatory regulator TIPE2 inhibits TLR4-mediated development of colon cancer via caspase-8. Cancer Biomark 2014; 14: 233\u2013240.","journal-title":"Cancer Biomark"},{"key":"BFcgt20173_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3892\/ol.2013.1388","volume":"6","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Qi H, Hou S, Jin X . TIPE2 mRNA overexpression correlates with TNM staging in renal cell carcinoma tissues. Oncol Lett 2013; 6: 571\u2013575.","journal-title":"Oncol Lett"},{"key":"BFcgt20173_CR29","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1007\/s13277-015-4388-9","volume":"37","author":"X Li","year":"2016","unstructured":"Li X . TIPE2 regulates tumor-associated macrophages in skin squamous cell carcinoma. Tumour Biol 2016; 37: 5585\u20135590.","journal-title":"Tumour Biol"},{"key":"BFcgt20173_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/cgt.2010.67","volume":"18","author":"Y Xie","year":"2011","unstructured":"Xie Y, Sheng W, Miao J, Xiang J, Yang J . Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells. Cancer Gene Ther 2011; 18: 176\u2013188.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt20173_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/cgt.2015.59","volume":"23","author":"H Zhang","year":"2016","unstructured":"Zhang H, Zhou X, Xu C, Yang J, Xiang J, Tao M et al. Synergistic tumor suppression by adenovirus-mediated ING4\/PTEN double gene therapy for gastric cancer. Cancer Gene Ther 2016; 23: 13\u201323.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt20173_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFcgt20173_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R . Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178\u2013196.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcgt20173_CR34","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1245\/s10434-007-9461-1","volume":"14","author":"Y Kosaka","year":"2007","unstructured":"Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, Mimori K et al. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Ann Surg Oncol 2007; 14: 2543\u20132549.","journal-title":"Ann Surg Oncol"},{"key":"BFcgt20173_CR35","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3748\/wjg.15.1499","volume":"15","author":"N Dai","year":"2009","unstructured":"Dai N, Lu AP, Shou CC, Li JY . Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer. World J Gastroenterol 2009; 15: 1499\u20131505.","journal-title":"World J Gastroenterol"},{"key":"BFcgt20173_CR36","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ncb1173","volume":"6","author":"BP Zhou","year":"2004","unstructured":"Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931\u2013940.","journal-title":"Nat Cell Biol"},{"key":"BFcgt20173_CR37","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/ncb1508","volume":"8","author":"JI Yook","year":"2006","unstructured":"Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 2006; 8: 1398\u20131406.","journal-title":"Nat Cell Biol"},{"key":"BFcgt20173_CR38","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1038\/onc.2013.279","volume":"33","author":"SH Kao","year":"2014","unstructured":"Kao SH, Wang WL, Chen CY, Chang YL, Wu YY, Wang YT et al. GSK3beta controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug. Oncogene 2014; 33: 3172\u20133182.","journal-title":"Oncogene"},{"key":"BFcgt20173_CR39","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ccr.2014.07.025","volume":"26","author":"SA Fayngerts","year":"2014","unstructured":"Fayngerts SA, Wu J, Oxley CL, Liu X, Vourekas A, Cathopoulis T et al. TIPE3 is the transfer protein of lipid second messengers that promote cancer. Cancer Cell 2014; 26: 465\u2013478.","journal-title":"Cancer Cell"},{"key":"BFcgt20173_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2014.09.017","volume":"26","author":"LS Moniz","year":"2014","unstructured":"Moniz LS, Vanhaesebroeck B . A new TIPE of phosphoinositide regulator in cancer. Cancer Cell 2014; 26: 443\u2013444.","journal-title":"Cancer Cell"},{"key":"BFcgt20173_CR41","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1038\/onc.2014.208","volume":"34","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Liang X, Gao L, Ma H, Liu X, Pan Y et al. TIPE1 induces apoptosis by negatively regulating Rac1 activation in hepatocellular carcinoma cells. Oncogene 2015; 34: 2566\u20132574.","journal-title":"Oncogene"},{"key":"BFcgt20173_CR42","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA . A perspective on cancer cell metastasis. Science 2011; 331: 1559\u20131564.","journal-title":"Science"},{"key":"BFcgt20173_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B De Craene","year":"2013","unstructured":"De Craene B, Berx G . Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13: 97\u2013110.","journal-title":"Nat Rev Cancer"},{"key":"BFcgt20173_CR44","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1096\/fj.09-151639","volume":"24","author":"MG Mendez","year":"2010","unstructured":"Mendez MG, Kojima S, Goldman RD . Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J 2010; 24: 1838\u20131851.","journal-title":"FASEB J"},{"key":"BFcgt20173_CR45","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/ncb2976","volume":"16","author":"A Puisieux","year":"2014","unstructured":"Puisieux A, Brabletz T, Caramel J . Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol 2014; 16: 488\u2013494.","journal-title":"Nat Cell Biol"},{"key":"BFcgt20173_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2131","volume":"7","author":"H Peinado","year":"2007","unstructured":"Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415\u2013428.","journal-title":"Nat Rev Cancer"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt20173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt20173","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt20173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T13:05:36Z","timestamp":1647954336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt20173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFcgt20173"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2017.3","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]},"assertion":[{"value":"30 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}